| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | disease | BEFREE | The aim of this study was to investigate the clinical significance of CSCs markers (Lgr5, Oct4, CD133, EpCAM, CD54 and Sox2) and establish a new model based on these markers to accurately predict prognosis of GC. | 27557490 | 2016 | ||||
|
0.080 | Biomarker | disease | BEFREE | The HER-2 positive SGC-7901 secreted more transforming growth factor beta 1 (TGF-β1) and resultantly activated MMP-9 to enhance s-ICAM-1 secretion and further studies showed that phosphatidylinositol-3 kinase (PI3K)/Akt/NF-κB signaling pathway was involved in GC pathogenesis. | 25613482 | 2015 | ||||
|
0.080 | Biomarker | disease | BEFREE | Furthermore, leptin induced GC cell (AGS and MKN-45) migration by upregulating ICAM-1, and knockdown of ICAM-1 by small interference RNA (siRNA) blocked this process. | 24548863 | 2014 | ||||
|
0.080 | GeneticVariation | disease | BEFREE | The association of ICAM-1 K469E polymorphisms and the risk of GC were studied, and the correlation of ICAM-1 K469E polymorphisms with the clinicopathological parameters and prognosis of the patients with complete clinical and follow-up data was analyzed. | 22294843 | 2012 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Syndrome differentiation in traditional Chinese medicine and E-cadherin/ICAM-1 gene protein expression in gastric carcinoma. | 17708604 | 2007 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | CD54 expression is predictive for lymphatic spread in human gastric carcinoma. | 16416166 | 2005 | ||||
|
0.080 | Biomarker | disease | BEFREE | We have reported that ICAM-1 gene transfection was effective against lymph node metastases of gastric cancer. | 15522320 | 2004 | ||||
|
0.080 | Biomarker | disease | BEFREE | In the present study, we investigated whether ICAM-1 gene therapy for the peritoneal metastasis of gastric carcinoma is useful as a new immuno-gene therapy. | 12373302 | 2002 |